CEO Magnus René: “Arcam is Healthy, EBM Patents Far from Maturing”. Next Gen Systems in the Works? AM Industry
In a recent article I wondered whether CEO Magnus René’s decision to leave the company was the result of the company’s failure to introduce high profile new products over the last year or other conflicts arising following the acquisition by GE. Mr. René kindly agreed to discuss these issues clarifying that business has never been better at the company and that he chose to leave only because he felt his cycle was complete, after bringing Arcam from a startup to a major global player.